Enlivex Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enlivex Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $75k | 81k | 0.93 |
| 2025-03-31 | $10k | 10k | 0.97 |
| 2024-12-31 | $12k | 10k | 1.17 |
| 2024-09-30 | $18k | 10k | 1.68 |
| 2024-06-30 | $15k | 10k | 1.42 |
| 2024-03-31 | $40k | 10k | 3.79 |
| 2023-09-30 | $17k | 10k | 1.58 |
| 2023-06-30 | $27k | 10k | 2.63 |
| 2023-03-31 | $38k | 10k | 3.64 |
| 2022-12-31 | $40k | 10k | 3.84 |
| 2022-09-30 | $44k | 10k | 4.22 |
| 2022-06-30 | $47k | 10k | 4.51 |
| 2022-03-31 | $58k | 10k | 5.57 |
| 2021-12-31 | $65k | 10k | 6.24 |
| 2021-09-30 | $102k | 10k | 9.79 |